Cendrine Tourette

Cendrine Tourette has worked in a variety of roles in the medical field. Cendrine began their career in 2001 as an Undergraduate Student at Nucleica SA. In 2003, they joined INSERM as a PhD student, researching Genomic analysis of early mutant polyglutamine cytotoxicity in C. elegans. Cendrine then served as a Research Engineer at INSERM, performing Genetic and molecular analysis of mutant polyglutamine cytotoxicity in C. elegans. In 2009, Tourette was a Post-doctoral fellow in Neurosciences at the Buck Institute for Research on Aging. From 2013 to 2018, they were a Translational and Clinical Project Manager at Greater Paris University Hospitals - AP-HP. Currently, they are a Translational and clinical research project leader in neuromuscular diseases at Biophytis - LIVE HEALTHIER LONGER.

Cendrine Tourette obtained their Doctor of Philosophy (PhD) in Neuroscience from Pierre and Marie Curie University in 2008.